WINNERS & LOSERS: Asos sells Lichfield centre; CelLBxHealth revenue up
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 6.50p on 07-07-2026 at 18:35:05 |
|---|---|
| Change | -0.22p -3.23% |
| Buy | 7.00p |
| Sell | 6.00p |
| Last Trade: | Buy 44,000.00 at 6.60p |
| Day's Volume: | 152,699 |
| Last Close: | 6.60p |
| Open: | 6.66p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 6.14p - 6.66p |
| 52wk Range: | 6.14p - 12.10p |
| Market Capitalisation: | £417.95m |
| VWAP: | 6.443584p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 44,000 | 6.60p | Suspected BUY Trade |
16:35:03 - 07-Jul-26 |
| Sell* | 15,725 | 6.385p | Ordinary |
14:04:57 - 07-Jul-26 |
| Buy* | 5,000 | 6.52p | Suspected BUY Trade |
14:00:25 - 07-Jul-26 |
| Buy* | 30,000 | 6.64p | Ordinary |
09:09:56 - 07-Jul-26 |
| Buy* | 4,126 | 6.64p | Ordinary |
09:07:07 - 07-Jul-26 |
| Sell* | 46,200 | 6.14p | Uncrossing Trade |
09:00:07 - 07-Jul-26 |
| Sell* | 766 | 6.00p | Ordinary |
08:00:40 - 07-Jul-26 |
| Sell* | 266 | 6.00p | SI Trade |
08:00:20 - 07-Jul-26 |
| Buy* | 16 | 7.00p | SI Trade |
08:00:20 - 07-Jul-26 |
| Buy* | 6,600 | 6.66p | Suspected BUY Trade |
08:00:02 - 07-Jul-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |
| 23rd Feb 2026 7:51 am | RNS | Update on funding and total voting rights |
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |